Primary Job Title CEO Primary Organization Interline Therapeutics
Location South San Francisco, California, United States Regions San Francisco Bay Area, West Coast, Western US Gender Male
LinkedIn View on LinkedIn
Zachary Sweeney is the Chief Scientific Officer at Denali. In this role, he supports the biology, discovery pharmacology, genomics, small molecule and biotherapeutic discovery groups.
Before joining Denali, Zach was a director and scientific investigator at the Novartis Institutes for Biomedical Research. He also worked as a scientist and team
leader at Genentech and Roche. His teams have contributed to the identification of more than a dozen candidate medicines for the treatment of neurodegenerative diseases, inflammatory diseases and infectious diseases, and six of these molecules have progressed into clinical studies. Zach has co-authored approximately 60 patent applications and 35 scientific articles.
Zach graduated from Stanford University, received a Ph.D. in chemistry from the University of California, Berkeley, and completed a NIH-postdoctoral fellowship at Harvard University.
